GARRY ARTHUR NEIL - Chief Executive Officer, Director at Avalo Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Issuer Symbol
AVTX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by GARRY ARTHUR NEIL since 11 Mar 2025

Holdings reported by GARRY ARTHUR NEIL for Avalo Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 129,733 $1,686,529 $13.00 28 Mar 2025 Direct Common Stock
Common Stock 47,140 $398,804 $8.46 28 Mar 2025 Direct
Stock Option (Right to Buy) 286,000 26 Feb 2026 Direct Common Stock

Transactions reported by GARRY ARTHUR NEIL for Avalo Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.